Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.

Autor: Montemagno, Christopher1 (AUTHOR), Jacquel, Arnaud2 (AUTHOR), Pandiani, Charlotte3 (AUTHOR), Rastoin, Olivia4 (AUTHOR), Dawaliby, Rosie5 (AUTHOR), Schmitt, Thomas2 (AUTHOR), Bourgoin, Maxence2 (AUTHOR), Palenzuela, Héliciane5 (AUTHOR), Rossi, Anne-Laure3 (AUTHOR), Ambrosetti, Damien6 (AUTHOR), Durivault, Jerome1 (AUTHOR), Luciano, Frederic3 (AUTHOR), Borchiellini, Delphine7 (AUTHOR), Le Du, Julie4 (AUTHOR), Gonçalves, Leticia Christina Pires4 (AUTHOR), Auberger, Patrick2 (AUTHOR), Benhida, Rachid4,8 (AUTHOR), Kinget, Lisa9,10 (AUTHOR), Beuselinck, Benoit9,10 (AUTHOR), Ronco, Cyril4,8,11 (AUTHOR)
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 3/19/2024, Vol. 43 Issue 1, p1-19. 19p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje